Agile Therapeutics (AGRX +29.3%) is up on below-average volume on the heels of a positive Ad Com vote on contraceptive patch Twirla last week. Shares have rallied almost five-fold since then.
The FDA’s action date is Saturday, November 16, so a decision should be announced the day before.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.